News and Trends 3 Jul 2015
Nobel Prize’s company start gathering robust clinical data in two phases II
Cell Therapy’s Tendoncel, a topical gel for the treatment of severe tendon injuries, has successfully completed its phase II. The…
Cardiovascular disease
- Latest Posts
News and Trends 19 Jun 2015
Celyad, the new face of Cardio3, is launching an IPO on NASDAQ
[UPDATE 19/06/2015]: Yesterday, Celyad launched its IPO on NASDAQ and the closing is expected to occur on 24 June 2015. Celyad,…
News and Trends 3 Jun 2015
Poor topline results for NeuroVive’s CicloMulsion Phase III
Phase III is a critical step in a drug development process. NeuroVive Pharmaceutical has learned this the hard way. The Swedish…
News and Trends 27 May 2015
NewCo, the union of Sorin and Cyberonics
[UPDATE 27/05/2015]: Sorin' shareholders approved the merger with Cyberonics in an Extraordinary Meeting. Sorin and Cyberonics, agreed on a merger…
ADVERTISEMENT
News and Trends 15 Apr 2015
Heart Metabolics bargain with the FDA for a single Phase III
Heart Metabolics received an agreement letter from the FDA related to the company's proposed phase III trial Special Protocol Assessment…
News and Trends 11 Apr 2015
Cardio3 Biosciences Embedded BioLife Solutions for a Heart Regenerative Therapy
Cardio3 BioSciences is again on the front page of biotech news. After announcing the launching of an IPO on Nasdaq and…
News and Trends 7 Apr 2015
A New Key Strategic Collaboration Between BMS and UniQure
Last month, Bristol-Myers Squibb (BMS) and UniQure, the Dutch pioneer in human gene therapy, were at the forefront of the scene…
News and Trends 2 Apr 2015
Interview with CELLPROTHERA, the regenerative medicine pioneer
CellProthera is a medical biotech company founded in 2008 in Mulhouse, France. The young innovative company focuses on the use…
News and Trends 12 Feb 2015
Neurostimulation, an Innovative Approach to Treat Heart Failure
The revolutionary Equilia system, meant to treat heart failure, has been successfully implanted for the first time in a clinical study…
News and Trends 4 Oct 2014
A Hydrogel to treat Advanced Heart Failure in Europe
LoneStar Heart, Inc. announced that it received the CE Mark (European Conformity) for its Algisyl-LVR® hydrogel implant,a product for the treatment of…
News and Trends 3 Sep 2014
EMA give Orphan Drug Designation to the CER-001 of Cerenis
Cerenis Therapeutics, the biopharmaceutical company developing CER-001, an engineered human apoA-I-containing pre-beta HDL mimetic, for the treatment of cardiovascular disease,…
News and Trends 31 Aug 2014
Why should you drink tea instead of coffee?
Drinking tea reduces non-cardiovascular mortality by 24%, reveals a study in 131 000 people presented at ESC Congress today by…
